Delivery Order SPE2DB20D2014-SPE2DB25FB67M

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,498.25, is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a diabetes medication. The contract has a firm fixed price pricing type and an ultimate completion date of March 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,040.65 firm fixed-price contract is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes medication. The contract has a completion date of May 29, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,332.94 firm fixed-price contract is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes medication. The delivery order has a June 2025 completion date and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,237.61, is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a medication used for diabetes management. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside and is an open competition....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $50,218.49 and a performance period ending on June 26, 2025. The contract is not set aside and was competed openly. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a $29,889.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a medical supply product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,491.38 contract is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes medication, with a performance period through June 2025. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for the Defense...
This is a $46,067.92 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes medication, with a period of performance through June 2025. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes medication. The total ceiling value of the award is $33,787.61, with a period of performance ending on November 19, 2021. The contract is not set aside for any specific business type, indicating open competition. Amerisourcebergen...
This is a $44,792.11 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication, with a performance period through March 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB67M
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,886.19, is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a diabetes medication. The contract has an ultimate completion date of April 18, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This contract positions AmerisourceBergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/17/25, 2:13 PM